- Home
- LGND vs CLOV Comparison
LGND vs CLOV Comparison
Compare LGND & CLOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGND
- CLOV
- Stock Information
- Founded
- LGND 1987
- CLOV 2014
- Country
- LGND United States
- CLOV United States
- Employees
- LGND N/A
- CLOV N/A
- Industry
- LGND Biotechnology: Pharmaceutical Preparations
- CLOV Medical Specialities
- Sector
- LGND Health Care
- CLOV Health Care
- Exchange
- LGND Nasdaq
- CLOV Nasdaq
- Market Cap
- LGND 2.0B
- CLOV 1.9B
- IPO Year
- LGND 1992
- CLOV N/A
- Fundamental
- Price
- LGND $108.55
- CLOV $3.47
- Analyst Decision
- LGND Strong Buy
- CLOV Strong Buy
- Analyst Count
- LGND 7
- CLOV 3
- Target Price
- LGND $144.67
- CLOV $4.83
- AVG Volume (30 Days)
- LGND 116.1K
- CLOV 5.9M
- Earning Date
- LGND 05-08-2025
- CLOV 05-06-2025
- Dividend Yield
- LGND N/A
- CLOV N/A
- EPS Growth
- LGND N/A
- CLOV N/A
- EPS
- LGND N/A
- CLOV N/A
- Revenue
- LGND $167,133,000.00
- CLOV $1,370,664,000.00
- Revenue This Year
- LGND $16.47
- CLOV $47.67
- Revenue Next Year
- LGND $19.44
- CLOV $13.64
- P/E Ratio
- LGND N/A
- CLOV N/A
- Revenue Growth
- LGND 27.28
- CLOV 8.52
- 52 Week Low
- LGND $69.17
- CLOV $0.62
- 52 Week High
- LGND $129.90
- CLOV $4.87
- Technical
- Relative Strength Index (RSI)
- LGND 53.94
- CLOV 44.16
- Support Level
- LGND $101.24
- CLOV $3.24
- Resistance Level
- LGND $111.39
- CLOV $3.54
- Average True Range (ATR)
- LGND 5.67
- CLOV 0.22
- MACD
- LGND 0.82
- CLOV -0.00
- Stochastic Oscillator
- LGND 84.05
- CLOV 66.50
About LGND Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.
About CLOV Clover Health Investments Corp.
Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.